Long QT syndrome in extensive infective endocarditis complicating hypertrophic obstructive cardiomyopathy

Kardiologia Polska

Volumn 67, Issue 1, 2009, Pages 53-57

  Yuan, Shi Min ^a   Demosthenous, Eugene ^a   Coman, Vera ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

Aortic valve replacement; Hypertrophic obstructive cardiomyopathy; Infective endocarditis; Long QT syndrome; Mitral valve replacement

Indexed keywords

ADULT; AORTA VALVE REPLACEMENT; ARTICLE; BACTERIAL ENDOCARDITIS; CASE REPORT; CLINICAL FEATURE; ELECTROCARDIOGRAM; FEMALE; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; LONG QT SYNDROME; MITRAL VALVE REPAIR; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

EID: 63049130405     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Alessandri N, Pannarale G, del Monte F, et al. Hypertrophic obstructive cardiomyopathy and infective endocarditis: a report of seven cases and a review of the literature. Eur Heart J 1990; 11: 1041-8.
2. Khan IA. Long QT syndrome: diagnosis and management. Am Heart J 2002; 143: 7-14.
3. Yap YG, Camm AJ. Drug induced QT prolongation and torsades de pointes. Heart 2003; 89: 1363-72.
4. Zhou J, Meng R, Li X, et al. The effect of arsenic trioxide on QT interval prolongation during APL therapy. Chin Med J (Engl) 2003; 116: 1764-6.
5. Oakley CM. Mitral valve palpitations. Aust N Z J Med 1992; 22 (5 Suppl.): 562-5.
6. Familoni OB, Alebiosu CO, Ayodele OE. Effects and outcome of haemodialysis on QT intervals and QT dispersion in patients with chronic kidney disease. Cardiovasc J S Afr 2006; 17: 19-23.
7. Chiang CE. Congenital and acquired long QT syndrome. Current concepts and management. Cardiol Rev 2004; 12: 222-34.